# Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine

> **NCT04264598** · PHASE1 · COMPLETED · sponsor: **Jiangsu Province Centers for Disease Control and Prevention** · enrollment: 100 (actual)

## Conditions studied

- Polio

## Interventions

- **BIOLOGICAL:** sIPV
- **BIOLOGICAL:** Commercialized sIPV
- **BIOLOGICAL:** Commercialized IPV

## Key facts

- **NCT ID:** NCT04264598
- **Lead sponsor:** Jiangsu Province Centers for Disease Control and Prevention
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-21
- **Primary completion:** 2017-12-19
- **Final completion:** 2018-12-28
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2020-02-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04264598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04264598, "Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04264598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*